Vaccination of Triple Negative Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Breast Neoplasms
Interventions: BIOLOGICAL: P10s-PADRE with MONTANIDE™ ISA 51 VG + Doxorubicin + Cyclophosphamide + Paclitaxel|DRUG: Doxorubicin + Cyclophosphamide + Paclitaxel
Sponsor: University of Arkansas